FI883807A0 - Förfarande för framställning av farmakologiskt aktiva 7-(3-substituerad-1-pyrrolidinyl)-1-cyklopropyl-1,4-dihydro-4-oxo-1,8-naftyridin-3-karboxylsyraderivat - Google Patents

Förfarande för framställning av farmakologiskt aktiva 7-(3-substituerad-1-pyrrolidinyl)-1-cyklopropyl-1,4-dihydro-4-oxo-1,8-naftyridin-3-karboxylsyraderivat

Info

Publication number
FI883807A0
FI883807A0 FI883807A FI883807A FI883807A0 FI 883807 A0 FI883807 A0 FI 883807A0 FI 883807 A FI883807 A FI 883807A FI 883807 A FI883807 A FI 883807A FI 883807 A0 FI883807 A0 FI 883807A0
Authority
FI
Finland
Prior art keywords
naphthyridine
pyrrolidinyl
cyclopropyl
dihydro
oxo
Prior art date
Application number
FI883807A
Other languages
English (en)
Finnish (fi)
Other versions
FI883807A (sv
FI90237C (sv
FI90237B (sv
Inventor
Joseph Peter Sanchez
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of FI883807A0 publication Critical patent/FI883807A0/sv
Publication of FI883807A publication Critical patent/FI883807A/sv
Priority to FI913697A priority Critical patent/FI91636C/sv
Application granted granted Critical
Publication of FI90237B publication Critical patent/FI90237B/sv
Publication of FI90237C publication Critical patent/FI90237C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI883807A 1987-08-21 1988-08-17 Förfarande för framställning av farmakologiskt aktiva 7-(3-substituerad-1-pyrrolidinyl)-1-cyklopropyl-1,4-dihydro-4-oxo-1,8-naftyridin-3-karboxylsyraderivat FI90237C (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI913697A FI91636C (sv) 1987-08-21 1991-08-02 Förfarande för framställning av antibakteriska kinolonföreningar

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8795087A 1987-08-21 1987-08-21
US8795087 1987-08-21
US07/220,177 US4851418A (en) 1987-08-21 1988-07-20 Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent
US22017788 1988-07-20

Publications (4)

Publication Number Publication Date
FI883807A0 true FI883807A0 (sv) 1988-08-17
FI883807A FI883807A (sv) 1989-02-22
FI90237B FI90237B (sv) 1993-09-30
FI90237C FI90237C (sv) 1994-01-10

Family

ID=26777552

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883807A FI90237C (sv) 1987-08-21 1988-08-17 Förfarande för framställning av farmakologiskt aktiva 7-(3-substituerad-1-pyrrolidinyl)-1-cyklopropyl-1,4-dihydro-4-oxo-1,8-naftyridin-3-karboxylsyraderivat

Country Status (16)

Country Link
US (1) US4851418A (sv)
EP (1) EP0304087B1 (sv)
JP (1) JP2679818B2 (sv)
KR (1) KR0120389B1 (sv)
AU (1) AU608881B2 (sv)
CA (1) CA1339216C (sv)
DE (1) DE3888754T2 (sv)
DK (1) DK172152B1 (sv)
ES (1) ES2063011T3 (sv)
FI (1) FI90237C (sv)
HK (1) HK1000802A1 (sv)
IE (1) IE62787B1 (sv)
NO (1) NO171979C (sv)
NZ (1) NZ225870A (sv)
PH (1) PH25460A (sv)
PT (1) PT88289B (sv)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79189A (en) * 1985-06-26 1990-07-12 Daiichi Seiyaku Co Quinoline and/or naphthyridine-4-oxo-3-carboxylic acid derivatives,process for their preparation and pharmaceutical compositions comprising them
IN166416B (sv) * 1985-09-18 1990-05-05 Pfizer
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
FI88506C (sv) * 1986-07-04 1993-05-25 Chemie Linz Gmbh Förfarande för framställning av farmaceutiskt användbar 7-diazabicyklo alkyl-6-fluor-1-(2,4-difluorfenyl)-1,4-dihydro-4-oxo-kinolin-3-karboxy lsyra eller karboxylsyraester
US4780468A (en) * 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents
IL90062A (en) * 1988-04-27 1994-10-07 Daiichi Seiyaku Co History of pyridonecarboxylic acid, their preparation and pharmaceutical preparations containing them
CA1340285C (en) * 1988-05-19 1998-12-22 Hiroyuki Nagano Novel quinolonecarboxylic acid derivatives having at 7-position a piperidin-1-yl substituent
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
FI95130C (sv) * 1988-07-20 1995-12-27 Sankyo Co Förfarande för framställning av som läkemedel användbara derivat av 4-oxokinolin-3-karboxylsyra
US5057520A (en) * 1989-03-24 1991-10-15 Abbott Laboratories 7-(peptidylpyrolidinyl)naphthyridine antibacterial compounds
US5057523A (en) * 1988-09-22 1991-10-15 Abbott Laboratories Dipeptide quinolone derivatives
IE76284B1 (en) * 1988-09-22 1997-10-08 Abbott Lab Amino acid quinoline and naphthyridine derivatives
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
EP0366189A3 (en) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial lactam-quinolones
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
US4916141A (en) * 1989-03-28 1990-04-10 Warner-Lambert Company (S)-7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid
CA2012681A1 (en) * 1989-03-31 1990-09-30 Masayasu Okuhira Quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same
DE3910920A1 (de) * 1989-04-05 1990-10-11 Bayer Ag Enantiomerenreine 7-(3-amino-1-pyrrolidinyl)-chinolon- und -naphthyridoncarbonsaeuren
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5385913A (en) * 1989-10-06 1995-01-31 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
WO1991004972A1 (en) * 1989-10-06 1991-04-18 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
US5084276A (en) * 1990-01-05 1992-01-28 Abbott Laboratories Quinolone carboxylic acid compositions with polymeric additive to reduce vein irritation
WO1991016327A1 (en) 1990-04-18 1991-10-31 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactams
AU6367690A (en) * 1990-07-10 1992-05-21 Hokuriku Pharmaceutical Co. Ltd. Optically active thiazetoquinoline-3-carboxylic acid compound, method for preparation thereof, and a pharmaceutical composition comprising the same
US5342846A (en) * 1990-12-05 1994-08-30 Synphar Laboratories, Inc. 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents
CA2058640A1 (en) * 1991-01-25 1992-07-26 Richard R. Scherschlicht Tricyclic pyridone derivative
ZA92803B (en) 1991-02-06 1992-11-25 Igen Inc Method and apparatus for magnetic microparticulate based luminescene asay including plurality of magnets
FR2673426B1 (fr) * 1991-03-01 1993-07-16 Bouchara Sa Nouvelles quinolones, leur procede de preparation et les compositions en refermant.
FR2676445B1 (fr) * 1991-05-16 1995-02-03 Esteve Labor Dr Derives de pyridone amino acide azetidinyl substitues, leur preparation et leur application en tant que medicaments.
ES2151488T3 (es) * 1991-05-28 2001-01-01 Daiichi Seiyaku Co Derivado de acido piridonacarboxilico.
US5177217A (en) * 1992-04-27 1993-01-05 Warner-Lambert Company Process for the manufacture of (S)-3-amino-1-substituted-pyrrolidines
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
US5290794A (en) * 1992-10-27 1994-03-01 Warner Lambert Co. Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms
WO1994025464A1 (en) * 1993-04-24 1994-11-10 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
KR950018003A (ko) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 신규한 퀴놀론 유도체 및 그의 제조 방법
RU2140919C1 (ru) * 1994-07-18 1999-11-10 Убе Индастриз Лтд. Производные 8-трифторметилхинолинкарбоновой кислоты, фармацевтическая композиция и способ ингибирования вируса иммунодефицита
US5602254A (en) * 1995-05-26 1997-02-11 Warner-Lambert Company Method for making quinoline carboxylic acids or naphthyridine carboxylic acids in free base form
ES2178701T3 (es) * 1995-06-15 2003-01-01 Pfizer Procedimiento para preparar derivados del acido azabiciclo naftriridina carboxilico que comprenden un dipeptido.
JP4057088B2 (ja) * 1996-04-22 2008-03-05 株式会社カネカ ピロリジン誘導体の製造方法
US6136823A (en) * 1996-11-28 2000-10-24 Wakunaga Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivatives or salts thereof and drugs containing the same as the active ingredient
US6608078B2 (en) 2000-05-08 2003-08-19 Wockhardt Limited Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment
US7098219B2 (en) 2000-08-01 2006-08-29 Wockhart Limited Inhibitors of cellular efflux pumps of microbes
SE0003795D0 (sv) 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6878713B2 (en) 2001-04-25 2005-04-12 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
WO2003099815A1 (en) 2002-05-28 2003-12-04 Wockhardt Limited Crystalline fluoroquinolone arginine salt form
KR20120030558A (ko) 2003-09-04 2012-03-28 욱크하트 리미티드 벤조퀴놀리진-2-카복실산 아르기닌 염 사수화물
WO2005035493A1 (ja) * 2003-10-08 2005-04-21 Teijin Pharma Limited アミノピロリジン誘導体の製造方法および中間体化合物
KR100939347B1 (ko) 2005-07-20 2010-01-29 (주)카이로드 광학적으로 순수한 (ｓ)-3-히드록시 피롤리딘의 제조방법
CN101239937B (zh) * 2007-02-07 2010-05-19 上海雅本化学有限公司 一种光学活性r-(-)-1-苄氧羰基-3-氨基吡咯烷及其盐酸盐的制备方法
AU2008276512A1 (en) * 2007-07-17 2009-01-22 Amgen Inc. Thiadiazole modulators of PKB
US7902227B2 (en) * 2007-07-27 2011-03-08 Janssen Pharmaceutica Nv. C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents
CN101983187A (zh) * 2008-04-02 2011-03-02 株式会社钟化 (s)-3-(1-氰基-1，1-二苯基甲基)吡咯烷的制备方法
US8445700B2 (en) 2008-11-24 2013-05-21 Council Of Scientific & Industrial Research Process for the preparation of optically active N-benzyl-3 hydroxypyrrolidines
CN114989165A (zh) * 2022-05-30 2022-09-02 青岛大学附属医院 一种抗持留菌和生物膜菌的化合物或组合物及其用途
EP4382529A1 (en) 2022-12-07 2024-06-12 Bayer Consumer Care AG A process for preparing pure (3s)-pyrrolidin-3-ol and pure (3s)-pyrrolidin-3-ol hydrochloride

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5630964A (en) * 1979-08-22 1981-03-28 Kyorin Pharmaceut Co Ltd Novel substituted quinolinecarboxylic acid and its preparation
JPS58174367A (ja) * 1982-04-07 1983-10-13 Tanabe Seiyaku Co Ltd キノリン誘導体及びその製法
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
DE3306771A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPS60126271A (ja) * 1983-12-09 1985-07-05 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
ZA85853B (en) * 1984-02-17 1986-09-24 Warner Lambert Co Antibacterial agents
JPS60178867A (ja) * 1984-02-24 1985-09-12 Dai Ichi Seiyaku Co Ltd ジハロゲノキノリン誘導体
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
JPS60250573A (ja) * 1984-05-25 1985-12-11 富士通株式会社 電気接続用ソケツト
JPS61205258A (ja) * 1985-03-08 1986-09-11 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体及びその製造方法
US4657913A (en) * 1985-04-18 1987-04-14 Warner-Lambert Company Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents
JPS62469A (ja) * 1985-06-27 1987-01-06 Dainippon Pharmaceut Co Ltd 新規キノロン誘導体、そのエステルおよびその塩
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents

Also Published As

Publication number Publication date
FI883807A (sv) 1989-02-22
PT88289B (pt) 1995-03-31
DK172152B1 (da) 1997-12-01
FI90237C (sv) 1994-01-10
NO883722L (no) 1989-02-22
DE3888754D1 (de) 1994-05-05
NO171979B (no) 1993-02-15
JPH01125371A (ja) 1989-05-17
KR890003704A (ko) 1989-04-17
PH25460A (en) 1991-07-01
DE3888754T2 (de) 1994-07-14
PT88289A (pt) 1989-09-14
IE62787B1 (en) 1995-02-22
EP0304087A2 (en) 1989-02-22
KR0120389B1 (ko) 1997-11-04
HK1000802A1 (en) 1998-05-01
NO883722D0 (no) 1988-08-19
ES2063011T3 (es) 1995-01-01
EP0304087A3 (en) 1989-10-25
CA1339216C (en) 1997-08-05
NZ225870A (en) 1990-12-21
US4851418A (en) 1989-07-25
EP0304087B1 (en) 1994-03-30
NO171979C (no) 1993-05-26
DK467388A (da) 1989-02-22
AU2062988A (en) 1989-02-23
AU608881B2 (en) 1991-04-18
DK467388D0 (da) 1988-08-19
JP2679818B2 (ja) 1997-11-19
IE882363L (en) 1989-02-21
FI90237B (sv) 1993-09-30

Similar Documents

Publication Publication Date Title
FI883807A0 (sv) Förfarande för framställning av farmakologiskt aktiva 7-(3-substituerad-1-pyrrolidinyl)-1-cyklopropyl-1,4-dihydro-4-oxo-1,8-naftyridin-3-karboxylsyraderivat
NO176605C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive 7-(1-azetidinyl)-1,4-dihydro-4-okso-3-kinolinkarboksylsyrederivater
NO882732L (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO175531C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive imidazo(4,5-b)-kinolinyloksyalkansyreamider
FI91152B (sv) Förfarande för framställning av terapeutiskt aktiva bensimidazolderivat
NO860332L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alfa-(2-okso-2,4,5,6,7,7a-heksahydro-tieno(3,2-c)-5-pyridyl)-fenyl-eddiksyre-derivater.
NO863061D0 (no) Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater.
NO884231D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazopyridin-derivater.
NO864425D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater.
FI95570C (sv) Förfarande för framställning av medicinskt verkande pyridazinon-3(2H)-onderivat
NO871295D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO176713C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-aminopyridinderivater
PT87153A (pt) Process for the preparation of acid ribofuranuronic derivatives
FI871087A (sv) Förfarande för framställning av terapeutiskt användbara 1,2,3,4-tetrahydro-3-karbamoyl-2-tioxo/oxo-5-pyrimidinkarboxylsyraderivat
FI93444B (sv) Förfarande för framställning av terapeutiskt aktiva dihydropyridinföreningar
NO870049D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
FI890723A (sv) Förfarande för framställning av kinolinkarboxylsyraderivat
NO881333D0 (no) Fremgangsmaate for fremstilling av imidazo-pyridinderivater
PT86998A (pt) Process for the preparation of a pharmaceutical compound containing as active ingredient the acid 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4h-pyrano (3,2-g) quinoline-2,8-dicarboxylic
PT88116A (pt) Process for preparing naphthalenepropionic acid derivatives useful as anti-inflammatory/antiallergic agents
NO164243C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive 16,17-acetalsubstituerte pregnan-21-oinsyrederivater
FI93725B (sv) Förfarande för framställning av optiskt aktiva, högervridande oxo-isoindolinylderivat
FI93008B (sv) Förfarande för framställning av antibakteriella 6-fluor-1,4-dihydrokinol-4-on-3-karboxylsyraderivat
FI893121A (sv) Förfarande för framställning av terapeutiskt aktiva 6,21-dimetyl-19-norprogestronderivat
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: WARNER-LAMBERT COMPANY

MA Patent expired